Reported 1 day ago
Inspire Medical Systems, Inc. (NYSE:INSP) announced positive clinical outcomes for its Inspire V system in treating obstructive sleep apnea, showcasing a 20% reduction in surgical times and improved respiratory sensing compared to the previous Inspire IV system. The data was sourced from a restricted U.S. market release and a clinical study in Singapore, indicating the effectiveness of their innovative approach in medical technology.
Source: YAHOO